TABLE 1

Baseline Characteristics

CharacteristicsStudy DrugP
Placebo (N = 49)Atomoxetine (N = 44)
Age, mean (SD), y6.1 (0.5)6.1 (0.6).9
Childhood Autism Rating Scale, SD17.3 (2.2)17.0 (1.9).4
Gender, n (%).3
    Male31 (63)32 (73)
    Female18 (37)12 (27)
Ethnicity, n (%).07
    Hispanic or Latino6 (12)12 (27)
    Not Hispanic or Latino43 (88)32 (73)
Race, n (%).06a
    White39 (80)41 (93)
    Black or African American7 (14)3 (7)
    American Indian3 (6)
Grade in school, n (%).6
    Daycare1 (2)0 (0)
    Preschool5 (10)5 (11)
    Kindergarten23 (47)18 (41)
    First grade20 (41)19 (43)
    Second grade0 (0)2 (5)
ADHD subtype, n (%).9
    Inattentive4 (8)4 (9)
    Hyperactive/impulsive4 (8)5 (11)
    Combined41 (84)35 (80)
Comorbidities, n (%)
    Oppositional defiant disorder17 (35)15 (34).9
    Enuresis9 (18)7 (16).8
    Separation anxiety0 (0)1 (2).5
    Phobia5 (10)3 (7).7
    Tics1 (2)0 (0).9
    Other2 (4)3 (7).7
  • a The P value compares the proportion of subjects whose race was white between treatment groups.